Related Experiment Video
Updated: Oct 1, 2025
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Global impact of COVID-19 on newborn screening programmes
Vanesa Koracin1, J Gerard Loeber2, Matej Mlinaric1
1Department of Endocrinology, Diabetes and Metabolism, UMC - University Children's Hospital Ljubljana; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Introduction:
The global COVID-19 pandemic has presented extraordinary disruption to healthcare services and exposed them to numerous challenges. Newborn screening (NBS) programmes were also affected; however, scarce data exist on the impact of COVID-19 on NBS.
Methods:
We conducted an international survey to assess the global impact of COVID-19 on NBS, with the main aim of gathering the experiences of the COVID-19 pandemic from a large and representative number of NBS centres worldwide.
Results:
The results of our study showed that COVID-19 impacted the NBS programmes, at least partially, in 29 out of 38 responding countries. Majority of the screening centres experienced a broad spectrum of difficulties and most were affected more in the second wave of the pandemic. Delays and unreliability with the postal service as well as flight cancellations caused delays in samples arriving to screening centres and with the provision of laboratory equipment and reagents. The availability of laboratory staff was sometimes reduced due to infection, quarantine or reassignment within the healthcare facility. Sample collection at home, second-tier tests and follow-up were also affected. Social restrictions and interruptions in public transport added to these difficulties. Only a limited number of centres managed to retain a fully functioning NBS programme.
Conclusion:
As the pandemic might continue or could recur in future years, it would be useful to develop guidelines to protect these valuable services.
